Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $615 Billion
  • Q3 2024

Adar1 Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $615 Billion distributed in 278 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $48.1B, Protagonist Therapeutics, Inc with a value of $44.2B, Bridge Bio Pharma, Inc. with a value of $36.9B, Ea Series Trust with a value of $35.2B, and Roivant Sciences Ltd. with a value of $34.9B.

Examining the 13F form we can see an increase of $85.2B in the current position value, from $530B to 615B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $615 Billion
Healthcare: $433 Billion
ETFs: $6.5 Billion
Communication Services: $3.51 Billion
Utilities: $1.26 Billion
Technology: $995 Million
Industrials: $511 Million
Real Estate: $132 Million
Basic Materials: $121 Million
Other: $293 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$19.2M
$159 Million 0.03% of portfolio
244,966
Q3 2024 Added 31.7%
$131B
$210 Million 0.03% of portfolio
2,500
Q3 2024 New
$2.22B
$167 Million 0.03% of portfolio
5,000
Q1 2024 New
$791M
$209 Million 0.03% of portfolio
9,206
Q3 2024 Added 15.08%
$217M
$164 Million 0.03% of portfolio
14,143
Q3 2024 Added 17.66%
$216M
$206 Million 0.03% of portfolio
24,702
Q3 2024 Added 64.68%
$23M
$164 Million 0.03% of portfolio
120,013
Q3 2024 Added 34.82%
$252M
$199 Million 0.03% of portfolio
55,802
Q3 2024 Reduced 84.85%
$9.66M
$192 Million 0.03% of portfolio
403,716
Q3 2024 Added 13.65%
$1.2B
$170 Million 0.03% of portfolio
5,000
Q3 2024 Added 1,550.17%
$967M
$101 Million 0.02% of portfolio
1,700
Q3 2024 New
Black Hawk Acquisition Corp
-
$154 Million 0.02% of portfolio
-
Q3 2024 New
$68.9M
$151 Million 0.02% of portfolio
101,008
Q3 2024 Added 102.02%
$1.08B
$132 Million 0.02% of portfolio
20,000
Q3 2024 New
$2.16B
$121 Million 0.02% of portfolio
9,000
Q3 2024 New
Biohaven LTD
-
$132 Million 0.02% of portfolio
-
Q3 2024 New
$13.4M
$109 Million 0.02% of portfolio
282,131
Q3 2024 Reduced 76.97%
$759M
$92.9 Million 0.02% of portfolio
9,285
Q3 2024 New
$2.36B
$96.1 Million 0.02% of portfolio
12,000
Q2 2024 New
$4.87B
$117 Million 0.02% of portfolio
5,000
Q3 2024 Reduced 10.54%
$33.8M
$154 Million 0.02% of portfolio
24,322
Q3 2024 Reduced 78.5%
$253B
$129 Million 0.02% of portfolio
1,140
Q3 2024 Reduced 98.5%
$1.2B
$147 Million 0.02% of portfolio
15,700
Q3 2024 Reduced 29.91%
$1.38B
$98.9 Million 0.02% of portfolio
15,000
Q3 2024 New
Syros Pharmaceuticals Inc
-
$96.8 Million 0.02% of portfolio
-
Q3 2024 New
$219M
$121 Million 0.02% of portfolio
18,475
Q3 2024 Added 530.98%
$70.5M
$111 Million 0.02% of portfolio
142,958
Q3 2024 Added 53.79%
$372M
$48.5 Million 0.01% of portfolio
6,560
Q3 2024 Added 17.99%
$39.9M
$74.2 Million 0.01% of portfolio
8,727
Q3 2024 Reduced 97.28%
$910M
$79.4 Million 0.01% of portfolio
4,300
Q3 2024 Added 4,200.0%
$55.1M
$36.7 Million 0.01% of portfolio
10,000
Q1 2024 New
$24.7B
$60 Million 0.01% of portfolio
200
Q3 2024 Reduced 77.53%
$1.83B
$58 Million 0.01% of portfolio
4,000
Q3 2024 Reduced 81.82%
$1.68B
$39.9 Million 0.01% of portfolio
1,000
Q1 2024 New
$54.5M
$39.2 Million 0.01% of portfolio
51,000
Q3 2024 New
$46.6M
$73.9 Million 0.01% of portfolio
21,737
Q3 2024 New
$548M
$61.8 Million 0.01% of portfolio
3,000
Q3 2024 Added 328.57%
$188M
$64.9 Million 0.01% of portfolio
6,000
Q3 2024 Added 200.0%
Grail Inc
-
$60.6 Million 0.01% of portfolio
-
Q3 2024 Reduced 79.44%
Corbus Pharmaceuticals Hldgs
-
$82.5 Million 0.01% of portfolio
-
Q3 2024 Reduced 66.67%
$461M
$41.1 Million 0.01% of portfolio
10,000
Q3 2024 Reduced 81.95%
$59B
$62.9 Million 0.01% of portfolio
1,000
Q3 2024 New
$0
$49.1 Million 0.01% of portfolio
8,400
Q3 2024 New
$36.4M
$38.7 Million 0.01% of portfolio
10,000
Q3 2024 New
$3.85B
$45 Million 0.01% of portfolio
2,000
Q3 2024 New
$12.5B
$84.3 Million 0.01% of portfolio
1,200
Q3 2024 New
$306M
$71.4 Million 0.01% of portfolio
10,000
Q3 2024 New
$56.9M
$77.2 Million 0.01% of portfolio
44,635
Q3 2024 Reduced 4.39%
$1.12B
$86.5 Million 0.01% of portfolio
2,000
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 278
  • Current Value $615 Billion
  • Prior Value $530 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 89 stocks
  • Additional Purchases 75 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 70 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email